Rocket One (RKTO) Market Capitalization (2019 - 2026)
Rocket One's (RKTO) quarterly Market Capitalization came in at $23.2 million in Q2 2026, up 49.73% year-over-year from $15.5 million in Q2 2025, and up 69.58% quarter-over-quarter from $13.7 million in Q1 2026.
Analysis
Rocket One (RKTO) Market Capitalization (2019 - 2026) Analysis & Trends
Rocket One has disclosed Market Capitalization across 8 years of filings, most recently posting $23.2 million for Q2 2026.
- In Q2 2026, Market Capitalization rose 49.73% year-over-year to $23.2 million; the TTM figure through Jun 2026 stood at $23.2 million (up 49.73% YoY), while the FY2025 annual figure was $15.4 million, up 222.05% from the prior year.
- Market Capitalization came in at $23.2 million for Q2 2026 at Rocket One, up from $13.7 million in the prior quarter.
- In the past five years, Market Capitalization ranged from a high of $414.8 million in Q1 2022 to a low of $4.8 million in Q4 2024.
- Average Market Capitalization over 5 years is $51.6 million, with a median of $10.7 million recorded in 2022.
- Year-over-year, Market Capitalization tumbled 98.77% in 2023 and surged 303.38% in 2025.
- Over 5 years, Market Capitalization stood at $10.2 million in 2022, then slumped by 51.66% to $4.9 million in 2023, then slipped by 2.85% to $4.8 million in 2024, then soared by 222.05% to $15.4 million in 2025, then surged by 50.95% to $23.2 million in 2026.
- Per Business Quant data, the three most recent Market Capitalization figures were $23.2 million in Q2 2026, $13.7 million in Q1 2026, and $15.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.18 Mn |
| Mar 31, 2026 | 13.67 Mn |
| Dec 31, 2025 | 15.36 Mn |
| Sep 30, 2025 | 24.51 Mn |
| Jun 30, 2025 | 15.48 Mn |
| Mar 31, 2025 | 13.17 Mn |
| Dec 31, 2024 | 4.77 Mn |
| Sep 30, 2024 | 6.08 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 6.69 Mn |
| Dec 31, 2023 | 4.91 Mn |
| Sep 30, 2023 | 5.30 Mn |
| Jun 30, 2023 | 9.91 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 10.16 Mn |
| Sep 30, 2022 | 11.21 Mn |
| Jun 30, 2022 | 337.57 Mn |
| Mar 31, 2022 | 414.77 Mn |
| Dec 31, 2021 | 395.51 Mn |
| Sep 30, 2021 | 713.23 Mn |